Anti Cancer Target
Sep 11, 2017
HDAC (Histone Deacetylase) Inhibitors – A Promising Anti-Cancer Target
Histone deacetylase ( HDAC ) inhibitors are a new class of anti-cancer agents which play important roles in epigenetic or non-epigenetic regulation, including programmed cell death, and cell cycle arrest in cancer cells. Histone deacetylase inhibitors are either naturally occurring or they can be synthetically produ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
